急性心筋梗塞の診断における病院前トロポニン検査の調査:体系的レビュー
PubMedで要約を見る
まとめ
この要約は機械生成です。病院前の胸痛患者における心筋梗塞 (MI) の検出には,POC (Point-of-care) トロポニン検査が有望である. しかし,POCトロポニンはMIを完全に排除できないので,信頼性の高い病院前使用のためにさらなる研究が必要である.
科学分野
- 緊急 医療
- 心臓病科
- 診断技術
背景
- 胸痛は緊急診療の主要な原因であり,病院前での心筋梗塞 (MI) の診断は複雑である.
- 現在,入院前のMI診断は病歴と心電図に基づいており,ST上昇MI患者は,一次性皮経冠動脈干渉 (PPCI) に移送されています.
- トロポニン検査のために地元のEDに送られ,最終的な治療を遅らせます.
研究 の 目的
- 病院前での急性心筋梗塞 (MI) の検出におけるPOCトロポニン装置の有効性を体系的に検討する.
- 病院前 MI 診断と患者の管理を改善するための POC トロポニン検査の可能性を評価する.
主な方法
- PRISMAのガイドラインに従って実施された体系的なレビューです.
- CINAHL,MEDLINE,EMBASE,およびDISCOVERYのデータベースを介して広範な文献検索を行いました.
- 入院前の胸痛患者のPOCトロポニン検査を用いた研究を含む.
主要な成果
- 特定された5つの論文は,様々な病院前のPOCトロポニン装置が胸痛の患者でMIを検出できることを実証しました.
- 主な制限は,入院前のPOCトロポニン検査結果が陰性であった一部の患者が,後に入院中にMIと診断されたことでした.
- POCトロポニン検査は,入院前の環境で潜在的MIを排除することはありません.
結論
- POCトロポニン検査はMIの検出に役立つが,診断は排除できないため,さらなる調査が必要である.
- 病院前でのPOCトロポニン検査の信頼性を確立するには,さらなる研究が不可欠です.
- 病院前診断の改善により 専門のPPCIセンターへの移送が迅速になり 患者の治療結果と医療費の改善が可能になります
関連する概念動画
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

